Navigation Links
EntreMed in Medical Technology

Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients

... antitumor activity in preclinical models. entremed Vice President and Chief Medical Officer, Carolyn ...e pathology of hematological cancers. About entremed EntreMed, Inc. is a clinical-stage pharmaceutic...heumatoid arthritis. Additional information about entremed is available on the Company's web site at www.en...

EntreMed Presents Initial Clinical Results for ENMD-2076

...based chemotherapy in breast cancer. In addition, entremed has received an Orphan Drug Designation from the F...g candidate, a No Objection Letter was received by entremed from Health Canada permitting ENMD-2076 to be used...ther expand the clinical development of ENMD-2076, entremed has received a No Objection Letter (NOL) from the ...

EntreMed Receives New Patent for 2-Methoxyestradiol Analogs

...s of 2- methoxyestradiol (2ME2). The patent grants entremed composition-of-matter and method of use intellectu...MDLOGO ) Analogs of 2ME2 have been developed by entremed to improve metabolic stability and retain or enhan...s owned exclusively by EntreMed. James S. Burns, entremed President & Chief Executive Officer, commented, "T...

EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting

...taxel-resistant models. To date, MKC-1 has been evaluated in over 400 patients in multiple Phase 1 and 2 clinical trials. Carolyn F. Sidor, MD, MBA, entremed Vice President and Chief Medical Officer commented on the results, "Although we did not meet our overall goal for this study, we are encouraged by the...

EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting

...n/prnh/20010620/ENMDLOGO ) Mark R. Bray, Ph.D., entremed Vice President, Research, will give an oral presen...the special session, "New Drugs on the Horizon 2." entremed will share the podium with representatives from le...ies without cardiovascular effects. In addition, entremed scientists are scheduled for the following poster ...

EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program

...ogical cancers later this year." James S. Burns, entremed President & Chief Executive Officer commented, "EN... Phase 1 study will trigger a milestone payment by entremed pursuant to EntreMed's acquisition of Miikana Ther... Miikana stockholders, either in cash or shares of entremed common stock. About EntreMed EntreMed, Inc. is...

EntreMed Commences Continuous Dosing Clinical Trial For MKC-1

...effect with novel molecular imaging techniques," commented Dr. Glenn Liu. entremed Vice President and Chief Medical Officer, Carolyn F. Sidor, M.D., M.B.A., c... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in ...

EntreMed to Present at The New York Society of Security Analysts Industry Conference

...egulation and inflammation - processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission. CONTACT: ...

EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer

... of the cell cycle, and induce apoptosis. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, commented on the study, "Pancreat... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in ...

EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model

...survival in cancer patients. Mark R. Bray, Ph.D., entremed Vice President, Research, commented on the results...ot a registered trademark of EntreMed, Inc. About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198

...s overall antitumor effects. Mark R. Bray, Ph.D., entremed Vice President, Research, commented on the results...ny's web site at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Raises $20 Million to Support Clinical Development Program

...less fees, was funded at closing. James S. Burns, entremed President and Chief Executive Officer, commented on the financing, "This transaction provides entremed with a non-dilutive financing vehicle that strengt...Aurora-angiogenesis inhibitor in oncology." About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...

EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer

...ic breast cancer (MBC). The data were presented by entremed collaborators during the 2007 Breast Cancer Sympos...ny's web site at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds

...rapeutic agents. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, commente...w.entremed.com/">http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at

EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models

...in inhibitor compounds. The data were presented by entremed scientists at the American Association for Cancer ... identification. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, stated, ...quence, leading to cell death (apoptosis). About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...

EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting

...t candidate, ENMD-1198. The data were presented by entremed scientists and collaborators during two separate s...w.entremed.com/">http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at

EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers

...target="_blank" href= "http://www.entremed.com/">www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical company developing ther... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's website at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical company developing ther... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at entremed Vice President and Chief Medical Officer, commente...s a registered trademark of EntreMed, Inc. About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at

Clinical Results From EntreMed's Panzem NCD and Taxol Breast Cancer Study Presented at ASCO

...anisms of action. Carolyn F. Sidor, M.D., M.B.A, entremed Vice President and Chief Medical Officer, commente...enefit from treatment with Panzem(R) NCD." About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at
Other Tags
(Date:5/22/2015)... OXFORD, CT , May 22, 2015  NXT-ID, Inc. ... from June 1st, it will be ending its promotional pricing ... www.wocketwallet.com . Laurence Savin , Head of ... our exclusive promotional pricing until the end of May. To ... at wocketwallet.com/invite and when we open the store on June ...
(Date:5/21/2015)... 21, 2015 According to ... Solutions (Hardware, Software, Services), by Applications (Surveillance (Airborne, ... by End-Users (Military & Defense & Commercial) - ... Imaging Market is expected to grow from $7252.0 ... at a Compound Annual Growth Rate (CAGR) of ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2
(Date:5/29/2015)... (PRWEB) May 29, 2015 John A. ... to Cincinnati , The Department of Veterans Affairs (VA) ... Gennaro as the new director of the Cincinnati VA ... care to more than 43,000 unique Veterans annually and ... over 2,000 staff, CVAMC is a two-division campus located ...
(Date:5/29/2015)... 29, 2015 According to a recent HealthDay ... full-time workers has a substance abuse problem - the data, ... 111,500 adults with full-time jobs, revealed that 9.5% of those ... year. (1) The National Council on Alcoholism and Drug Dependence ... and an estimated 70% of the 14.8 million illicit drug ...
(Date:5/29/2015)... New York, NY (PRWEB) May 29, 2015 ... Pharmaceuticals unit have reached a confidential Risperdal lawsuit ... who allegedly developed gynecomastia due to his use ... the case had been selected for the third ... in a mass tort litigation underway in Pennsylvania’s ...
(Date:5/29/2015)... Inspire Nexus, a new social network officially launching ... many life coaches have asked, "How do I find ... to become a credentialed Coach?" , Many Life and ... long. Inspire Nexus, a social network for Coaches provides ... have experience coaching a certain number of hours, qualify ...
(Date:5/29/2015)... OncLive proudly announces the 2015 ... recognized by a panel of eminent oncologists for landmark ... Honorees will be introduced and celebrated TONIGHT at the ... 8:30-11:00 p.m. CDT at The Chicago Illuminating Company, 2110 ... recognized for groundbreaking accomplishments, in fields including translational research, ...
Breaking Medicine News(10 mins):Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4
Other Contents